Reports on the warning issued by several medical committee regarding a new data which shows an increase in mortality and cerebrovascular adverse events in elderly patients with dementia receiving olanzapine or risperidone. Risk factors of olanzapine treatment; Recommendation of the Committee for Proprietary...
Olanzapine may cause serious side effects such as an increased risk of death or stroke in elderly patients with dementia, a higher risk of suicide when taken with fluoxetine, metabolic changes, tardive dyskinesia, low blood pressure, and blood cell disorders. See the warnings below for a full ...
If you are prescribed olanzapine orally disintegrating tablets, do not take the tablet out and store it in a different container (such as a pill organizer) for future use. Make sure your hands are dry when handling the tablets. Place the tablet on your tongue and let it melt (no water ...
Olanzapine is not approved for the treatment of patients with dementia-related psychosis [see Warnings and Precautions (5.1), Use in Specific Populations (8.5), and Patient Counseling Information (17)]. When using olanzapine and fluoxetine in combination, also refer to the Boxed Warning section ...
The benefit of maintaining bipolar I patients on monotherapy with oral ZYPREXA at a dose of 5 to 20 mg/day, afterachieving a responder status for an average duration of 2 weeks, was demonstrated in a controlled trial [seeClinical Studies] . The healthcareprovider who elects to use ZYPREXA ...
individuals treated with antipsychotics for psychosis associated with dementia compared to placebo (RR 3.9, 95% CI 1.7–9.1). Meta-analysis of observational studies found a significant OR for pneumonia associated with antipsychotic use in patients with all age groups (OR 1.8, 95% CI 1.6–2.1); ...
Olanzapine is not for use in psychotic conditions related to dementia. Olanzapine may cause heart failure, sudden death, or pneumonia in older adults with dementia-related conditions. You should not take olanzapine if you are allergic to it. ...
Therapeutic Use Olanzapine is more effective than placebo and at least as effective as haloperidol in the treatment of overall psychopathology symptoms as shown in a number of randomised double-blind trials in patients with schizophrenia and related psychoses. ...
Olanzapine is effective in the treatment of overall and delayed chemotherapy-induced nausea and vomiting based on meta-analysis of RCTs [90,91]. Data for chronic nausea and emesis associated with gastroparesis is lacking. It is reasonable to use olanzapine for patients with nausea and emesis ...
A Review of Adverse Outcomes Associated with Psychoactive Drug Use in Nursing Home Residents with Dementia Treatment guidelines generally recommend careful assessment and non-pharmacological treatment approaches for behavioural and psychological symptoms of deme... Lapeyre-Mestre,Maryse - 《Drugs & Aging》 ...